Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immuron Limited ( (AU:IMC) ) has shared an announcement.
Immuron Limited has issued 116,680 ordinary shares without disclosure under Part 6D.2 of the Corporations Act, as per section 708A(5) of the Act. The company has complied with relevant provisions of the Corporations Act and confirms there is no excluded information required to be disclosed, indicating a transparent and compliant operation that may reassure stakeholders.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapy products for the treatment of gut-mediated diseases.
Average Trading Volume: 104,432
Technical Sentiment Signal: Sell
Current Market Cap: A$15.67M
See more data about IMC stock on TipRanks’ Stock Analysis page.